Kyverna Therapeutics, Inc.

NASDAQ:KYTX

Biotechnology

Healthcare
$4.48 -1.44%

-$0.12 today

Market cap
$283.23M
Beta
1.96
P/E (TTM)
-3.1
EPS (TTM)
-$2.59
52W Low $2.52High $13.67

Volume 1.05M

Average 0.94M

KYTX Short-term Debt

Borrowings and the current portion of long-term debt due within one year.

Kyverna Therapeutics, Inc.NASDAQ: KYTX

Short-term Debt · Q1 FY2026 · quarter ended Mar 2026

Short-term debt remains negative

Q1 FY2026 short-term debt was $0, compared with $0 a year earlier.

Context

  • Short-term debt amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Short-term debt increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0-100.0% QoQ
Last fiscal yearDec 2025
$0— YoY
Year agoMar 2025
$0— since
Short-term Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Short-term Debt history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Short-term Debt vs competitors

How KYTX compares with its peers on the latest reported figures

  • KYTX's Mar 2026 short-term debt of $0 is the 7th highest of the 11 companies compared; the peer median is $3.91M.
  • Short-term debt amounts to 0.0% of total assets for KYTX, versus a peer median of 1.2%.
KYTX Competitors Peer median
Short-term Debt for KYTX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
CABACabaletta Bio, Inc.Mar 2026$23.12M ——15.6%
EDITEditas Medicine, Inc.Mar 2026$14.2M ——9.5%
LYELLyell Immunopharma, Inc.Mar 2026$9.36M ——2.7%
ALLOAllogene Therapeutics, Inc.Mar 2026$8.42M ——2.1%
CAPRCapricor Therapeutics, Inc.Mar 2026$7.18M +752.7%+74.5%2.2%
AVIRAtea Pharmaceuticals, Inc.Mar 2026$634K ——0.2%
KYTXKyverna Therapeutics, Inc.Mar 2026$0 ——0.0%
SLNSilence Therapeutics plcMar 2026$0 ——0.0%
CTNMContineum Therapeutics, Inc. Class A Common StockMar 2026$0 ——0.0%
LXEOLexeo Therapeutics, Inc. Common StockMar 2026$0 ——0.0%
MREOMereo BioPharma Group plcMar 2026$0 ——0.0%
Peer median (excluding KYTX) $3.91M+752.7%+74.5%1.2%

Competitors are the stored peer set for KYTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents76.07M37.74M34.65M96.62M124.09M
Short-term Investments013.59M22.9M189.36M155.16M
Net Receivables00000
Inventory00000
Other Current Assets1.02M1.93M3.12M4.62M3.7M
Total Current Assets77.09M53.25M60.66M290.6M282.95M
Property, Plant & Equipment (Net)7.81M12.44M10.61M10.66M5.42M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets593K1.23M3.92M5.26M5.45M
Total Non-current Assets8.4M13.67M14.53M15.92M10.87M
Total Assets85.49M66.92M75.2M304.65M293.83M
Account Payables773K1.45M4.36M4.62M5.31M
Short-term Debt00000
Tax Payables00000
Deferred Revenue6M0000
Other Current Liabilities1.72M565K9.77M4.88M9.99M
Total Current Liabilities15.93M11.95M19.86M33.76M36.49M
Long-term Debt000024.74M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)1.03M0000
Other Non-current Liabilities110.05M6K000
Total Non-current Liabilities115.81M8.29M6.16M4.3M25.06M
Total Liabilities131.74M20.25M26.02M38.06M61.55M
Common Stock00001K
Retained Earnings(46.78M)(75.68M)(136.04M)(263.52M)(424.83M)
Accumulated OCI0(26K)4K105K97K
Other Stockholders Equity0(0)000
Minority Interest00000
Total Equity(46.25M)46.68M49.18M266.59M232.28M
Total Debt5.56M10.56M9.08M8.24M29.03M
Net Debt(70.51M)(27.17M)(25.57M)(88.38M)(95.06M)

Kyverna Therapeutics, Inc.

NASDAQ:KYTX

Intrinsic Alpha fair value

Locked

Current Price

$4.48

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.